Sayed, C. .; Shi, V. .; Hsiao, J.; Kokolakis, G. .; Kirby, B.; Piguet, V. .; Davis, L.; Bari, M. .; Madden, C. .; Knowles, S.; Prens, E. Bimekizumab Efficacy by Prior Biologic Treatment in Patients With Moderate to Severe Hidradenitis Suppurativa: 48-Week Pooled Data from the Randomized, Double-Blind, Placebo-Controlled, Multicenter BE HEARD I and II Phase 3 Trials. J of Skin 2024, 8, s349.